William M. Miles, MD, FHRS University of Florida College of Medicine Gainesville, FL ICD Implantation: Genetic Arrhythmia Syndromes.

Slides:



Advertisements
Similar presentations
LQTS Outline Background Identification Therapies Available
Advertisements

EP Testing and Use of Devices in Heart Failure HFSA 2010 Recommendations.
Management of the Patient Presenting with Wide Complex Tachycardia
Sudden Cardiac Death in Structurally Normal Heart
Sudden Cardiac Death Prevention: Clinical Trials Alena Goldman, MD September 9, 2004.
Brugada’s Syndrome and Sudden Cardiac Death
Cardiovascular Disaster in Hemodialysis patients
Ventricular Tachycardia
Normal Heart VT.
Genetic Testing in Patients with Arrhythmia and Risk for Sudden Cardiac Death : Indications and Implications for Practice Mary Gertrude Ong-Cordovez, M.D.
Prevention de la Mort Subite Treatment of Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death S. Nasr, M.D. Clinical Cardiac Electrophysiologist.
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Brugada Syndrome Carly Thompson MD CCFP EM Resident July 31, 2008.
Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)
IN THE NAME OF GOD.
Thursday 4/12/2014 Hassan Alahmadi Medical Resident ( R1)
1. Etiology of Hypertrophic Cardiomyopathy is mostly due to: A. Long-term Hypertension B. Aortic Stenosis C. Myocardial Ischemia D. Familial and Genetic.
Ventricular Arrhythmias
Congenital Heart Disease: Outcome in Patients with Single Ventricle
Syncope AM Report 6/25/10 Nicole Wilde. Syncope  Cause Not Obvious Neurally Mediated (vasovagal) 58% Cardiac Disease (arrhythmias) 23% Neurologic or.
ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW
Indications of ICD in 2010 Dr Mervat Aboulmaaty Professor of Cardiology Ain Shams University DAF 1 st EP course 2010.
Gregoratos G. et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
EP Show – Aug 2003 ICDs – Primary prevention The EP Show: Which ICD for which patient? Part 2: Primary prevention Eric Prystowsky MD Director, Clinical.
Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Christian van.
Sudden Cardiac Arrest: George Washington University Medical Center
Ventriclar Tachycardia
Clinical Teaching Case Anthony Battad MD, FRCPC University of Manitoba.
Devices and the older patient with syncope Michael Gammage, Reader in Cardiovascular Medicine MHRA Committee for Safety of Devices.
EP Show – Aug 2003 ICDs – Secondary prevention The EP Show: Which ICD for which patient? Part 1: Secondary prevention Eric Prystowsky MD Director, Clinical.
An Electrical Storm 9 th May 2014 U Buckley, D Eaton, J Galvin, T Keelan Mater Misericordiae Hospital, Dublin.
By Mahmoud Shah Professor of cardiology Zagazig university
ICD Indications T he Guidelines and Beyond University of Minnesota Medical Center Fei Lü, M.D., Ph.D., F.A.C.C., F.H.R.S. Associate Professor of Medicine.
Device and Antiarrhythmic Drugs: Advantages and Pitfalls Teresa Menendez Hood, M.D.
The Electrical Management of Cardiac Rhythm Disorders Tachycardia Indications for ICD Implantation.
Patient work up – the arrhythmia nurse perspective Hilary Bugden RN, MSc Papworth Hospital Cambridge.
An ICD for every CRT patient ?
ECG etc… (Miscellaneous ECGs) Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Charmaine J. Palafox, MD. Approx. 50% of CHD deaths occurs as sudden cardiac arrest.
The Heart has 3 Main Electrical channels that “fire” with every heart beat: –Sodium (Na + ), Potassium (K + ), Calcium (Ca ++ ) These 3 channels are in.
© 2008, American Heart Association. All rights reserved. AHA/ACC/HRS Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying.
ECG Workshop in Cardiac Ion Channel Diseases Dr. Ngai-Shing Mok Dept of Medicine & Geriatrics Princess Margaret Hospital Hong Kong.
Dr. Frank L.Y. Tam Queen Elizabeth Hospital Cardiology Division.
L ONG QT SYNDROME Katie DePlatchett, M.D. AM Report April 7, 2010.
ICD’s: Current Roles and Evidence Shariff Attaya M.D. Senior Talk Case Western Reserve University.
Ventricular Arrhythmias:A General Cardiologist’s Assessment of Therapies in 2004 C.Richard Conti M.D. MACC.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prevalence and Characteristics of Early Repolarization.
Ethical Scenario: Cardiovascular System
Wearable Cardioverter Defibrillators
Sudden Cardiac Arrest Morhaf Ibrahim, MD, FHRS Electrophysiology.
Disclosures None.
Implantable Defibrillator Therapy Post Cardiac Arrest
Next-generation sequencing increases the diagnostic yield in aborted sudden cardiac death caused by hereditary heart disease   Brøndberg AK1, Christiansen.
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Developed in Collaboration.
Brugada’s Syndrome and Sudden Cardiac Death
Arrhythmogenic right ventricular dysplasia
HYPERTROPHIC CARDIOMYOPATHY(HCM)
The EP show: sudden death, part 1 Director
ICD’s: Current Roles and Evidence
Syncope in children.
Volume 13, Issue 11, Pages (November 2016)
Volume 15, Issue 10, Pages e190-e252 (October 2018)
Volume 15, Issue 10, Pages e73-e189 (October 2018)
Molecular biology and the prolonged QT syndromes
Volume 11, Issue 2, Pages (February 2014)
Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival  T. Jared Bunch, MD, Stephen C. Hammill, MD, Roger.
Volume 12, Issue 10, Pages (October 2015)
Alcoholic Cardiomyopathy and Ventricular Arrhythmias
Presentation transcript:

William M. Miles, MD, FHRS University of Florida College of Medicine Gainesville, FL ICD Implantation: Genetic Arrhythmia Syndromes

Genetic Arrhythmia Syndromes  Long- and short-QT syndromes  Brugada syndrome  Idiopathic VF  Catecholaminergic polymorphic VT Most of these patients have no evidence of structural heart disease or LV dysfunction, and long-term prognosis is excellent if the arrhythmia is controlled.

Indications for ICD Implantation: Genetic Arrhythmia Syndromes ICD may be considered (Class IIb)  Primary prevention Patients with long QT syndrome and risk factors for SCD  e.g. markedly prolonged QTc or T wave alternans, “malignant” mutation

Indications for ICD Implantation: Genetic Arrhythmia Syndromes ICD implantation is indicated (Class I)  Secondary prevention Survivors of cardiac arrest after exclusion of completely reversible causes ICD implantation is reasonable (Class IIa)  Secondary prevention Patients with long-QT syndrome who are having syncope and/or VT while receiving beta blockers Patients with Brugada syndrome who have had Syncope Documented VT that has not resulted in cardiac arrest Patients with catecholaminergic polymorphic VT with syncope and/or sustained VT while receiving beta blockers